Miles for Myeloma History

2023: The 19th Annual Miles for Myeloma

In 2023, patients and their families gathered to hear our research and enhanced patient care team talk about IU’s plans to make myeloma history.  With philanthropic support, physician-scientists have continued to use the latest advances in genomic sequencing, machine learning and drug discovery to better understand the disease, and IU leads clinical trials for the newest options in immunotherapy. The room was filled with hope for the future.

Read Dr. Abonour’s 2023 thank you letter.

 

Our community is in a great place where people believe in science to overcome a variety of illnesses and continue to generously contribute to our fight against myeloma.

Dr. Rafat Abonour

#ResearchCuresCancer

Support Our Research